New hope for Tough-to-Treat lymphoma: trial tests Next-Gen cell therapy
NCT ID NCT06486051
Summary
This trial is testing a new, experimental CAR-T cell therapy called WZTL-002 for people with aggressive large B-cell lymphoma that has returned or not responded to standard chemotherapy. The main goals are to see how well the therapy works to eliminate the cancer and to understand its safety, particularly the risk of side effects affecting brain function. About 60 participants will have their own immune cells collected, modified to fight cancer, and then re-infused after a short course of chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Auckland City Hospital
RECRUITINGAuckland, 1023, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Christchurch Hospital
RECRUITINGChristchurch, Christchurch Central, 8011, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wellington Hospital
RECRUITINGNewtown, Wellington Region, 6021, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.